AI-Powered Neurological Screening Platform for Parkinson's Disease & Epilepsy

A comprehensive system combining wearable biosensing hardware with a mobile application for real-time neurological assessment, tremor analysis, and seizure screening.

NeuroSense


Overview

NeuroSense is an affordable, portable neurological screening platform that combines:

Key Stats:


The Problem

65 million people worldwide live with neurological disorders requiring continuous monitoring.

Challenge Impact
Parkinson's diagnosis delayed by 5-7 years Late intervention, reduced quality of life
30% of epilepsy patients have drug-resistant seizures Need 24/7 monitoring unavailable to most
Clinical equipment costs $15,000-$50,000 Inaccessible to underserved communities
Subjective clinical observation High inter-rater variability

Our Mission: Democratize neurological diagnostics through affordable, portable, AI-powered screening.